Hypericin, a potential new BH3 mimetic.
Front Pharmacol. 2022 Oct 4;13:991554. doi: 10.3389/fphar.2022.991554. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36267274
Free PMC article.